SEDAPAP Drug Patent Profile
✉ Email this page to a colleague
When do Sedapap patents expire, and what generic alternatives are available?
Sedapap is a drug marketed by Mayrand and is included in one NDA.
The generic ingredient in SEDAPAP is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEDAPAP?
- What are the global sales for SEDAPAP?
- What is Average Wholesale Price for SEDAPAP?
Summary for SEDAPAP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| DailyMed Link: | SEDAPAP at DailyMed |
US Patents and Regulatory Information for SEDAPAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayrand | SEDAPAP | acetaminophen; butalbital | TABLET;ORAL | 088944-001 | Oct 17, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
